한글목차

세계의 페니실린 G 나트륨 시장은 2024년에 2억 5,921만 달러로 평가되었고, 2030년에는 3억 9,733만 달러에 이를 전망이며, 예측 기간 동안 CAGR 4.80%를 보일 것으로 예측됩니다.

페니실린계 주사용 항생제인 페니실린 G 나트륨은 감수성이 높은 유기체에 의한 세균 감염증의 치료에 중요한 역할을 하고 있습니다. 그 임상 현장에서의 광범위한 용도는, 의약품 제조의 진보 및 적정 제조 규범(GMP)의 준수에 힘입어, 계속 시장 수요를 견인하고 있습니다. 제조 품질 및 규제 준수를 중시함으로써 주사용 페니실린 제제는 안전성과 유효성에 관한 국제 기준을 충족합니다.

시장은 헬스케어 지출 증가, 감염병 이환율 증가, 구명제에 대한 접근 확대에 중점을 둔 정부 주도 노력에 의해 더욱 자극되고 있습니다. 그러나 원료 가격의 변동, 발효 기반 생산 프로세스에 대한 의존, 정기적인 공급망 중단과 같은 과제가 제약이 되고 있습니다. 또한 지역에 따라서는 항생물질 내성에 대한 우려의 고조 및 처방 프로토콜의 엄격화가 특히 항균약의 과다 사용을 억제하는 대처에 있어서 사용을 억제할 가능성이 있습니다.

주요 시장 성장 촉진요인

제약 산업의 성장

주요 시장 과제

원재료 가격 변동

주요 시장 동향

제조위탁기관(CMO) 확대

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 페니실린 G 나트륨 시장에 미치는 영향

제5장 세계의 페니실린 G 나트륨 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 판매 채널별(직접, 간접)
  • 용도별(세균 감염증, 매독, 예방, 수막염, 병용 요법, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 페니실린 G 나트륨 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 페니실린 G 나트륨 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 페니실린 G 나트륨 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 페니실린 G 나트륨 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 페니실린 G 나트륨 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병 및 인수
• 제품 출시
• 최근 동향

제13장 세계의 페니실린 G 나트륨 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• North China Pharmaceutical Company.Ltd
• Henan Xinxiang Huaxing Pharmaceutical
• CSPC ZHONGNUO PHARMACEUTICAL(SHIJIAZHUANG) CO., LTD.
• Shandong Lukang Pharmaceutical Group Co., Ltd.
• Kangyuan Pharmaceutical Group
• Harbin Pharmaceutical Group

제16장 전략적 제안

제17장 기업 소개 및 면책사항

영문목차

The Global Penicillin G Sodium Market was valued at USD 259.21 Million in 2024 and is projected to reach USD 397.33 Million by 2030, growing at a CAGR of 4.80% during the forecast period. Penicillin G Sodium, an essential injectable antibiotic in the penicillin family, plays a critical role in treating bacterial infections caused by susceptible organisms. Its widespread application in clinical settings continues to drive market demand, supported by advancements in pharmaceutical manufacturing and adherence to Good Manufacturing Practices (GMP). The emphasis on production quality and regulatory compliance ensures that injectable penicillin formulations meet international standards for safety and efficacy.

The market is further stimulated by rising healthcare spending, increasing incidences of infectious diseases, and government-led initiatives focused on expanding access to life-saving medications. Nonetheless, challenges such as raw material price fluctuations, reliance on fermentation-based production processes, and periodic supply chain interruptions pose constraints. Additionally, growing concerns over antibiotic resistance and tighter prescribing protocols in some regions may temper usage, particularly in efforts to control antimicrobial overuse.

Key Market Drivers

Growth in Pharmaceutical Industry

The global pharmaceutical sector's expansion-particularly in emerging markets such as Asia-Pacific, Africa, and Latin America-is a major driver of demand for Penicillin G Sodium. The industry reached approximately USD 1.6 trillion in revenue by 2023, positioning it alongside the GDP of countries like Mexico or Australia. This robust growth reflects broader access to healthcare, improved medical infrastructure, and heightened health awareness. In these regions, governments and health providers are prioritizing low-cost, effective treatment options. Penicillin G Sodium, known for its reliability and affordability, remains a frontline therapy in combating bacterial infections and is widely included in public health procurement strategies.

Key Market Challenges

Volatility in Raw Material Prices

Price instability in key raw materials poses a significant challenge to the Penicillin G Sodium market. The fermentation-based production of this antibiotic depends on raw materials like corn steep liquor, lactose, and glucose-substances sensitive to agricultural yields, energy prices, and geopolitical disruptions. Any variation in the cost or supply of these inputs can directly impact manufacturing expenses. Manufacturers are particularly vulnerable to spikes in input prices, which either compress margins or necessitate price hikes, reducing competitiveness-especially in markets dominated by cost-sensitive generics. These fluctuations can disrupt supply continuity and affect global pricing structures for Penicillin G Sodium formulations.

Key Market Trends

Expansion of Contract Manufacturing Organizations (CMOs)

A prominent trend shaping the Penicillin G Sodium market is the growing role of Contract Manufacturing Organizations (CMOs). In 2024, CMOs and CDMOs are expected to experience a growth rate of 13.8%-second only to bioprocessing segments-highlighting their increasing importance in the pharmaceutical supply chain. These organizations provide pharmaceutical companies with cost-effective production solutions, allowing firms to reduce capital expenditures on specialized equipment and compliance infrastructure. Outsourcing to CMOs is particularly advantageous for generic drug makers aiming to maintain competitiveness in highly regulated and price-sensitive markets. The scalability, operational efficiency, and regulatory alignment offered by CMOs are driving their adoption, especially for antibiotic manufacturing.

Key Market Players

• North China Pharmaceutical Company Ltd.
• Henan Xinxiang Huaxing Pharmaceutical
• CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
• Shandong Lukang Pharmaceutical Group Co., Ltd.
• Kangyuan Pharmaceutical Group
• Harbin Pharmaceutical Group

Report Scope

In this report, the Global Penicillin G Sodium Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Penicillin G Sodium Market, By Sales Channel:

• Direct
• Indirect

Penicillin G Sodium Market, By End Use:

• Bacterial Infections
• Syphilis
• Prophylaxis
• Meningitis
• Combination Therapies
• Others

Penicillin G Sodium Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin G Sodium Market.

Available Customizations

Global Penicillin G Sodium Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Penicillin G Sodium Market

5. Global Penicillin G Sodium Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Sales Channel (Direct, Indirect)
  • 5.2.2. By End Use (Bacterial Infections, Syphilis, Prophylaxis, Meningitis, Combination Therapies, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Penicillin G Sodium Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Sales Channel
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Penicillin G Sodium Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Sales Channel
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Penicillin G Sodium Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Sales Channel
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Penicillin G Sodium Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Sales Channel
      • 6.3.3.2.2. By End Use

7. Europe Penicillin G Sodium Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Sales Channel
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Penicillin G Sodium Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Sales Channel
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Penicillin G Sodium Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Sales Channel
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Penicillin G Sodium Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Sales Channel
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Penicillin G Sodium Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Sales Channel
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Penicillin G Sodium Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Sales Channel
      • 7.3.5.2.2. By End Use

8. Asia Pacific Penicillin G Sodium Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Sales Channel
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Penicillin G Sodium Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Sales Channel
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Penicillin G Sodium Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Sales Channel
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Penicillin G Sodium Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Sales Channel
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Penicillin G Sodium Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Sales Channel
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Penicillin G Sodium Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Sales Channel
      • 8.3.5.2.2. By End Use

9. South America Penicillin G Sodium Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Sales Channel
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Penicillin G Sodium Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Sales Channel
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Penicillin G Sodium Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Sales Channel
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Penicillin G Sodium Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Sales Channel
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Penicillin G Sodium Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Sales Channel
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Penicillin G Sodium Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Sales Channel
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Penicillin G Sodium Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Sales Channel
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Penicillin G Sodium Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Sales Channel
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Penicillin G Sodium Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. North China Pharmaceutical Company.Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Henan Xinxiang Huaxing Pharmaceutical
• 15.3. CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.
• 15.4. Shandong Lukang Pharmaceutical Group Co., Ltd.
• 15.5. Kangyuan Pharmaceutical Group
• 15.6. Harbin Pharmaceutical Group

16. Strategic Recommendations

17. About Us & Disclaimer